California Public Employees Retirement System’s Fulcrum Therapeutics FULC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-30,000
Closed -$353K 2055
2021
Q1
$353K Hold
30,000
﹤0.01% 3144
2020
Q4
$351K Sell
30,000
-2,744
-8% -$31K ﹤0.01% 3121
2020
Q3
$260K Buy
32,744
+1,000
+3% +$12K ﹤0.01% 3149
2020
Q2
$581K Buy
+31,744
New +$500K ﹤0.01% 2595

Other funds holding FULC

California Public Employees Retirement System's FULC Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Fulcrum Therapeutics (FULC) in Q2 2021, closing a stake of 30,000 shares — an estimated $353K sold.

California Public Employees Retirement System first reported a position in FULC in Q2 2020 and held it in 4 quarters. The position peaked at $581K in Q2 2020. 67 funds tracked by Wall St. Rank hold FULC as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Fulcrum Therapeutics position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 30,000 Fulcrum Therapeutics shares in Q2 2021, an estimated $353K.
  • California Public Employees Retirement System first reported a position in Fulcrum Therapeutics in Q2 2020 and held it in 4 quarters.
  • California Public Employees Retirement System's Fulcrum Therapeutics position peaked at $581K in Q2 2020.
  • 67 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.